[New immune proteins and their perspectives for ophthalmology]

Research and progress in immunology and microbiology made the characterization and production of immunological active proteins possible. Lymphokines and monoclonal antibodies can be synthesized by new methods of gene technology and cell fusion techniques. These proteins meanwhile are of essential importance in biomedical research and are becoming an important tool in clinical medicine too. The possibility to modify the proteins or to label them with cytotoxic substances provides exciting aspects of medical progress for the future. Applications in ophthalmology hopefully will lead to new and successful ways for the diagnosis and therapy of ocular diseases.